Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celtic Pharma Holdings Advisors makes appointment

This article was originally published in Scrip

Executive Summary

Celtic Pharma Holdings Advisors, a private equity fund management partnership focused on the biotechnology and pharmaceutical industries, and advisor to the second Celtic Pharma fund, has appointed Dr Andy Richards to its advisory board. He is chairman of Altacor and Novacta Biosciences, and a non-executive director of Vectura Group, Summit, Biowisdom, Babraham Bioscience Technology, Cancer Research Technology and Arecor. Dr Richards has also advised the UK Government's Office of Life Sciences, which is led by the minister for science and innovation Lord Drayson, and UK Trade & Investment on biotechnology issues.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC004910

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel